The company said it hopes Manian can help advance its Point-of-Care (POCare) cellular therapy platform.
“Bala Manian will be a very important appointment to the Orgenesis Scientific Advisory Board,” CEO Vered Caplan said in a statement.
“We expect his scientific, medical and entrepreneurial background to make a significant contribution as Orgenesis enters the next phase of its growth. In particular, we look forward to leveraging his technical and medical expertise to help advance our point-of-care cell therapy platform, which we believe has the potential to transform the cell and gene therapy market,” he added.
READ: Orgenesis inks co-development agreement with Accellix to improve quality control in its cellular therapy system
“Having a widely respected visionary and entrepreneur of Bala’s caliber will also assist us in evaluating collaboration and in-licensing opportunities,” Caplan said.
Manian currently serves as a director of Vaccinex Inc (NASDAQ:VCNX), a clinical-stage company pioneering investigational antibody therapies in cancer and Huntington’s disease; is a director of Syngene International Ltd, a public contract research and manufacturing organization; a general partner of Saraswati Partners, a venture capital partnership, and a director at Equillium (NASDAQ:EQ), a clinical-stage biotechnology company developing products to treat severe autoimmune and inflammatory disorders.
Manian has operated as a serial inventor, founding a number of companies that utilize his optical technology in the life sciences sector, such as Lumisys (NASDAQ:LUMI), Digital Optics Corporation, Molecular Dynamics and Biometric Imaging.
At Biometric Imaging, he served as chief technical officer and led the development of a technology that enables doctors to examine the blood cells of very ill patients and determine the nature and extent of their disease.
Another of his technologies, the first three-color laser, helped filmmakers insert or merge special effects in movies. The laser was used in Star Wars: Return of the Jedi and Indiana Jones: The Last Crusade, and Manian received an Academy Award in 1999 for his work.
Additionally, he helped develop the first compact barcode laser scanner for supermarkets, while serving as a consultant. Over the years, Manian consulted about on-line quality control at companies including Ford Motor Company (NYSE:F), International Business Machines Corporation (NYSE:IBM), Corning Incorporated (NYSE:GLW), Kodak (NYSE:KODK), and the Union Pacific Corporation (NYSE:UNP).
Contact Andrew Kessel at firstname.lastname@example.org
Follow him on Twitter @andrew_kessel